fbpx

St. Luke’s among first in state to offer experimental COVID-19 treatment

St. Luke’s University Health Network said it is one of the first in Pennsylvania to use a new experimental drug for the treatment of COVID-19.

The health network said it has established a monoclonal antibody infusion center at its Easton Campus.

It plans to open a second center at St. Luke’s Warren Campus in Phillipsburg, N.J. next week.

The experimental drug, which was developed by Eli Lilly, is similar to the product that was given to President Donald Trump after contracting the virus last month.

“St. Luke’s is pleased to be collaborating with Pennsylvania and New Jersey health departments to advance this important COVID-19 treatment,” said infectious disease specialist Dr. Jeffrey Jahre, St. Luke’s chief medical officer. “This approach will help our hospitals avoid being overwhelmed during the current surge as certain high-risk patients who receive bamlanivimab recover in the comfort of their own homes.”

The use of monoclonal antibodies was recently granted emergency authorization by the U.S. Food and Drug Administration. The monoclonal antibodies block the COVID-19 virus’ attachment and entry into human cells.

St. Luke’s said Infusion has been found to be particularly effective in preventing the need for hospitalization in some, higher-risk patients including those who are 65 years of age or older and whose infection, identified early, does not yet require supplemental oxygen.

St. Luke’s noted that it was also one of the first health systems worldwide to use Masimo SafetyNet, a cloud-based patient management platform, to help clinicians care for patients remotely. It works by using a wireless sensor to monitor patients’ vital signs and provide doctors with valuable clinical data that helps to inform difficult treatment decisions such as when to use a ventilator.

Writer Stacy Wescoe has her finger on the pulse of the business community in the Greater Lehigh Valley and keeps you up-to-date with technology and trends, plus what coworkers and competitors are talking about around the water cooler — and on social media. She can be reached at swescoe@bridgetowermedia.com or 610-807-9619, ext. 4104. Follow her on Twitter and on Facebook.

Business Journal Events

Diversity and Inclusion Summit

Friday, March 19, 2021
Diversity and Inclusion Summit

Women of Influence Awards

Monday, May 03, 2021
Women of Influence Awards

Health Care Heroes

Tuesday, June 01, 2021
Health Care Heroes

Health Care Summit

Friday, August 06, 2021
Health Care Summit
/* code for sifitag */